The Use Of Cannabis For Medical Treatment In Malaysia: An Analytical Study From The Fiqh Al-Muwazanat Perspective
Keywords:
Cannabis, Fiqh al-Muwazanat, Maqasid Shariah, Maslahah, MafsadahAbstract
The ongoing debate surrounding the acceptability of utilising cannabis for medical treatment remains a prominent issue. The case of Muhammad Yasin Sulaiman in 2022 became the top discussion of the whole country because he was reported of planting 17 cannabis plants to treat his bipolar disorder. Many studies show the benefits of the chemical compositions of cannabis which are Tetrahydrocannabinol (THC) and Cannabidiol (CBD) in medical treatment. More than 70 countries have recognized the use of cannabis for medical purposes. However, the law in Malaysia is still maintaining its status quo by imposing legal action on individuals who possess and distribute cannabis. This issue has caused the government to be urged to immediately allow the use of cannabis in Malaysia. This research is a qualitative study by using the data collection method and analysis of the previous written sources. Hence, this study aims to analyze the use of cannabis in medical treatment from the perspective of Fiqh al-Muwazanat. The consideration between two contradictory matters should be done to achieve the principle of maqasid sharia. The data collected was obtained from books, journal articles, official websites of the authorities, and case studies. The results of the study have shown that the use of cannabis for medical treatment in Malaysia is considered to be allowed due to the mafsadah is greater than the maslahah. This is because there is an exceptional situation where the other medicine may not be available to preserve the life of a patient, thus the necessity for the cannabis to treat the patient shall be prevailed and this is in accordance with maqasid sharia.
Downloads
References
Agensi Antidadah Kebangsaan. (2022). Maklumat Dadah 2022. Kajang: Agensi Antidadah Kebangsaan. https://www.adk.gov.my/buku-maklumat-dadah-2022/
al-Burnu, M. S. (2003). Mausu'ah al-Qawaid al-Fiqhiyyah (1st ed.). Beirut: al-Resala Foundation.
al-Burnu, M. S. (1996). al-Wajiz fi Idah Qawaid al-Fiqh al-Kuliyyah (4th ed.). Beirut: al-Resala al-Alamia Foundation.
al-Khademi, N. (2001). 'Ilm al-Maqasid al-Shar'iyyah (1st ed.). Riyadh: Maktabat al-'Ubaykan.
al-Qaradhawi, Y. (1980). al-Halal wa al-Haram fi al-Islam (13th ed.). Beirut: al-Maktab al-Islami.
al-Qari, M. A. (2002). Mirqat al-Mafatih Sharh Mishkat al-Masabih (1st ed.). Beirut: Dar al-Fikr.
al-Sabuni, M. A. (2015.) Rawai al-Bayan Tafsir Ayat al-Ahkam min al-Quran (1st ed.). Jakarta: Dar al-Alamiyah.
al-Shanqeeti, M. M. (1994). Ahkam al-Jarahah al-Tibbiyyah wa al-Athar al-Mutarattibah 'Alaiha (2nd ed.). Jeddah: Maktabah al-Sahabah.
al-Syafie. (2004). Musnad al-Imam al-Syafie (1st ed.). Kuwait: Ghiras Publishing and Distribution Company.
al-Tayyar, A. (2011). al-Fiqh al-Muyassar (1st ed.). Riyadh: Madar al-Watan Publications.
General Presidency of the Departments of Scholarly Research, Ifta’, Da’wah, and Guidance. (n.d.). Majalah al-Buhuth al-Islamiyyah.
General Presidency of the Departments of Scholarly Research, Ifta’, Da’wah, and Guidance. (n.d.). Majalah al-Buhuth al-Islamiyyah.
Jabatan Kemajuan Islam Malaysia. (2011). Fiqh Al-Muwazanat: Hubungan dan Implikasinya Terhadap Fatwa (1st ed.). Putrajaya: Darul Tenggara (M) Sdn Bhd.
Kuwait Ministry of Awqaf and Islamic Affairs. (1982). Al-Mausu'ah Al-Fiqhiyyah Al-Kuwaitiyah (2nd ed.). Kuwait: Ministry of Awqaf and Islamic Affairs.
Majmu'atu Min al-Muallifin. (2003). Fiqh al-Muyassar Fi Daw’-il-Kitab wa-Sunnah. King Fahd Complex for the Printing of the Holy Qur'an.
Milad, A.N.K. (2005). al-Buyu' al-Muharramah wa al-Manhi 'anha (1st ed.). Mesir: Dar al-Huda al-Nabawi.
Journal
Devinsky, O., Nabbout, R., Miller, I., Laux, L., Zolnowska, M., Wright, S. & Robert, C. (2018). Long-Term Cannabidiol Treatment in Patients with Dravet Syndrome: An Open-Label Extension Trial. Epilepsia, 2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379690/
Devinsky, O., Nabbout, R., Miller, I., Laux, L., Zolnowska, M., Wright, S. & Robert, C. (2018). Long-Term Cannabidiol Treatment in Patients with Dravet Syndrome: An Open-Label Extension Trial. Epilepsia, 8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379690/
Ekmil Krisnawati Erlen Joni, Shahrul Mizan Ismail & Rohaida Nordin. (2023). The Medicinal Use of Cannabis Documented by Muslim Scientists. International Journal of Academic Research in Business and Social Sciences, 13(2), 591-592. http://dx.doi.org/10.6007/IJARBSS/v13-i2/16276
Huestis, M. A., Solimini, R., Pichini, S., Pacifici, R., Carlier, J. & Busardo, F.P. (2019). Cannabidiol Adverse Effects and Toxicity. Current Neuropharmacology, 17(10), 985. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052834
Indriyani & Anggi. (2022). Studi Tentang Efektivitas Cannabinoid Pada Ganja Dalam Pengobatan Epilepsi “Review Artikel”. Jurnal Pendidikan dan Konseling, 4(5), 8353-8357. https://journal.universitaspahlawan.ac.id/index.php/jpdk/article/view/8047
Johnson, R. (2019). Defining Hemp: A Fact Sheet. Congressional Research Service, 7, 1. https://sgp.fas.org/crs/misc/R44742.pdf
Lewandowska, J., Kapala, J.M. & Puchala, L. (2021). Therapeutic Potential of Dronabinol: A Systematic Review of Human Trials. Farmacja Polska, 484-489. https://polishpharmacy.ptfarm.pl/PF/editions/-/29174
Malasevskaia, I., al-Awadhi, A. A., Mohammed, L. (2020). Tea in the Morning and Khat Afternoon: Health Threats Due to Khat Chewing. Cureus, 12(12), 1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7842844/#:~:text=Although%20it%20is%20believed%20that,be%20the%20cause%20of%20cancer.
Mohamad Haniki Nik Mohamed, Nor Ilyani Mohamed Nazar, Irna Elina Ridzwan, Nor Hidayah Mohd Taufek & Norny Syafinaz Ab Rahman. (2022). Preventing Oversight on Medical Cannabis Legislation in Malaysia: Analysis of Risks, Benefits and Regulation Requirements. Journal of the Malaysian Parliament, 2, 11. https://doi.org/10.54313/journalmp.v2i.66
Mohamad Haniki Nik Mohamed, Nor Ilyani Mohamed Nazar, Irna Elina Ridzwan, Nor Hidayah Mohd Taufek & Norny Syafinaz Ab Rahman. (2022). Preventing Oversight on Medical Cannabis Legislation in Malaysia: Analysis of Risks, Benefits and Regulation Requirements. Journal of the Malaysian Parliament, 2, 250. https://doi.org/10.54313/journalmp.v2i.66
Mohamad Haniki Nik Mohamed, Nor Ilyani Mohamed Nazar, Irna Elina Ridzwan, Nor Hidayah Mohd Taufek & Norny Syafinaz Ab Rahman. (2022). Preventing Oversight on Medical Cannabis Legislation in Malaysia: Analysis of Risks, Benefits and Regulation Requirements. Journal of the Malaysian Parliament, 2, 261-262. https://doi.org/10.54313/journalmp.v2i.66
Mohamad Haniki Nik Mohamed, Nor Ilyani Mohamed Nazar, Irna Elina Ridzwan, Nor Hidayah Mohd Taufek & Norny Syafinaz Ab Rahman. (2022). Preventing Oversight on Medical Cannabis Legislation in Malaysia: Analysis of Risks, Benefits and Regulation Requirements. Journal of the Malaysian Parliament, 2, 255. https://doi.org/10.54313/journalmp.v2i.66
Mohamad Haniki Nik Mohamed, Nor Ilyani Mohamed Nazar, Irna Elina Ridzwan, Nor Hidayah Mohd Taufek & Norny Syafinaz Ab Rahman. (2022). Preventing Oversight on Medical Cannabis Legislation in Malaysia: Analysis of Risks, Benefits and Regulation Requirements. Journal of the Malaysian Parliament, 2, 254. https://doi.org/10.54313/journalmp.v2i.66
Pitts, L. (2020). Weaving Charlotte's Web: An In-Depth Guide to Cannabidiol. Honors Theses, 20. https://egrove.olemiss.edu/hon_thesis/1351
Pitts, L. (2020). Weaving Charlotte's Web: An In-Depth Guide to Cannabidiol. Honors Theses, 1-2. https://egrove.olemiss.edu/hon_thesis/1351
Pratt, M., Stevens, A., Thuku, M., Butler, C., Skidmore, B., Wieland, L.S., Clemons, M., Kanji, S. & Hutton, B. (2019). Benefits and Harms of Medical Cannabis: A Scoping Review of Systematic Reviews. Systhematic Reviews, 8, 2-3. https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-019-1243-x
Rahmat Dapari, Mohd Hafizuddin Mahfot, Ahmad Iqmer Nashriq Mohd Nazan, Mohd Rohaizat Hassan, Nazri Che Dom & Syed Sharizman Syed Abdul Rahim. (2022). Acceptance Towards Decriminalization of Medical Marijuana Among Adults in Selangor, Malaysia. PLoS ONE, 17(2), 14-15. https://doi.org/10.1371/journal.pone.0262819
Rahmat Dapari, Mohd Hafizuddin Mahfot, Ahmad Iqmer Nashriq Mohd Nazan, Mohd Rohaizat Hassan, Nazri Che Dom & Syed Sharizman Syed Abdul Rahim. (2022). Acceptance Towards Decriminalization of Medical Marijuana Among Adults in Selangor, Malaysia. PLoS ONE, 17(2), 3. https://doi.org/10.1371/journal.pone.0262819
Shahrul Mizan Ismail, Ekmil Krisnawati Erlen Joni & Rohaida Nordin. (2023). The Legality of Medical Cannabis from the Islamic Perspective. JUUM, 61. https://doi.org/10.17576/juum-2023-32-06
Shahrul Mizan Ismail, Ekmil Krisnawati Erlen Joni & Rohaida Nordin. (2023). The Legality of Medical Cannabis from the Islamic Perspective. JUUM, 55-57. https://doi.org/10.17576/juum-2023-32-06
Silva, G. D., Del Guerra, F.B., de Oliveira Lelis, M. & Pinto L.F. (2020). Cannabidiol in the Treatment of Epilepsy: A Focused Review of Evidence and Gaps. Front. Neurol, 11, 1-2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604476/
Silva, G. D., Del Guerra, F.B., de Oliveira Lelis, M. & Pinto L.F. (2020). Cannabidiol in the Treatment of Epilepsy: A Focused Review of Evidence and Gaps. Front. Neurol, 11, 3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604476/
Suppiah Nachiappan, Sandra Piriya Perumalsamy Fatimah Haji Mohd Zulkafaly & Harikrishnan Andi. (2014). Penyalahgunaan Dadah dan Langkah Mengatasi dari Segi Kognisi di Pusat Pengasih Malaysia. Jurnal Peradaban Melayu, 9, 183. https://ejournal.upsi.edu.my/index.php/JPM/article/view/1997
Tramer, M. R., Carroll, D., Campbell F.A., Reynolds, D.J.M., Moore R.A. & McQuay H.J. (2001). Cannabinoids for Control of Chemotherapy Induced Nausea and Vomiting: Quantitative Systematic Review. BMJ, 323, 18-19. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC34325/
Zaheer, S., Kumar, D., Khan, M.T., Giyanwani, P.R. & Kiran F.N.U. (2018). Epilepsy and Cannabis: A Literature Review. Cureus, 10(9), 1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235654/
Zaini Yusnita Mat Jusoh, Zanariah Dimon, Abdul Hakim Baharuddin & Asma’ Abdul Halim. (2024). Penggunaan Ganja Dalam Rawatan Penyakit Mental: Tinjauan dari Perspektif Hukum Syarak dan Perundangan di Malaysia: Satu Dapatan Awal. E-Jurnal Penyelidikan dan Inovasi, 11(1), 12. https://www.researchgate.net/publication/380512843_Penggunaan_Ganja_Dalam_Rawatan_Penyakit_Mental_Tinjauan_Dari_Perspektif_Hukum_Syarak_Dan_Perundangan_Di_Malaysia_Satu_Sorotan_Literatur
Proceedings
Abdul Hakim Baharudin, Zaini Yusnita Mat Jusoh, Zanariah Dimon, Sharifah Hana Abd Rahman & Asma Abdul Halim. (2023). Hukum Penggunaan Ganja Menurut Islam: Satu Kajian Literatur. E-Prosiding Persidangan Antarabangsa Sains Sosial & Kemanusiaan Kali ke-8, 1536-1537. https://www.researchgate.net/publication/372860320
Abdul Hakim Baharudin, Zaini Yusnita Mat Jusoh, Zanariah Dimon, Sharifah Hana Abd Rahman & Asma Abdul Halim. (2023). Hukum Penggunaan Ganja Menurut Islam: Satu Kajian Literatur. E-Prosiding Persidangan Antarabangsa Sains Sosial & Kemanusiaan Kali ke-8, 1533-1535. https://www.researchgate.net/publication/372860320
Zanariah Dimon, Zaini Yusnita Mat Jusoh, Abdul Hakim Baharudin, Sharifah Hana Abd Rahman & Asma' Abdul Halim. (2023). Kewajaran Penggunaan Ganja Dalam Perubatan: Satu Tinjauan Awal Dari Perspektif Undang-Undang di Malaysia. E-Prosiding Persidangan Antarabangsa Sains Sosial & Kemanusiaan kali ke-8, 708.
Act
Dangerous Drugs Act 1952.
Poison Act 1952.
Sale Of Drugs Act 1952.
Internet
Penggunaan Ganja Dalam Perubatan, Malaysia Masih Ketinggalan - Pakar. https://www.astroawani.com/berita-malaysia/penggunaan-ganja-dalam-perubatan-malaysia-masih-ketinggalan-pakar-407543 (accessed on: 8th September 2023).
Ubat Mengandungi Kanabis Mula Dibenar Tahun Depan. https://www.utusan.com.my/nasional/2022/07/produk-cbd-ada-kanabis-mula-dibenar-tahun-depan/ (accessed on: 28th November 2023).
Website
Food and Drug Administration. (2023, November 23). FDA and Cannabis: Research and Drug Approval Process. https://www.fda.gov/news-events/public-health-focus/fda-and-cannabis-research-and-drug-approval-process#:~:text=Cannabis-related%20compounds&text=FDA%20has%20approved%20Epidiolex%2C%20which,years%20of%20age%20and%20older
Food and Drug Administration. (2023, November 28). FDA and Cannabis: Research and Drug Approval Process. https://www.fda.gov/news-events/public-health-focus/fda-and-cannabis-research-and-drug-approval-process#:~:text=Cannabis-related%20compounds&text=FDA%20has%20approved%20Epidiolex%2C%20which,years%20of%20age%20and%20older
Pejabat Mufti Wilayah Persekutuan. (2023, December). Hukum Menanam Pokok Ketum Bagi Tujuan Perubatan & Farmaseutikal. Irsyad al-Fatwa Ke-124. https://muftiwp.gov.my/ms/artikel/irsyad-fatwa/irsyad-fatwa-umum/1242-irsyad-al-fatwa-ke-124-hukum-menanam-pokok-ketum-bagi-tujuan-perubatan-farmaseutikal
Pejabat Mufti Wilayah Persekutuan. (2023, October). Fatwa Berkenaan Hukum Menggunakan Dadah Jenis Kanabis. Warta Kerajaan Persekutuan. https://efatwa.muftiwp.gov.my/fatwa/PUB526%20FATWA%202022%20-%20FATWA%20BERKENAAN%20HUKUM%20MENGGUNAKAN%20DADAH%20JENIS%20KANABIS%20BAGI%20TUJUAN%20PERUBATAN
Program Perkhidmatan Farmasi. (2023, October). Soalan Lazim: Kanabis (Cannabis). Program Perkhidmatan Farmasi, Kementerian Kesihatan Malaysia. https://www.pharmacy.gov.my/v2/ms/entri/soalan-lazim-kanabis-cannabis.html
Audiovisual Media
Mufti Menk. (2023, December 6). Weed! Is It Really Haram? - Mufti Menk. [Video]. YouTube. https://youtu.be/tvaKtu-Do9s?si=J7bdwSzw8kVpmpKR
Case
Muhammad Lukman bin Mohamad v Public Prosecutor.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Muhammad Najib Abdullah, Intan Nadiah Mahraji
This work is licensed under a Creative Commons Attribution 4.0 International License.